Jeil Pharma Holdings, Up 11.82% on COVID-19 (Nafamostat) Theme Surge

On the 28th, the COVID-19 (Nafamostat) theme rose by 3.98% compared to the previous day, showing strength, while Jeil Pharma Holdings, which is attracting attention as a related stock, surged by 11.82% compared to the previous day. Jeil Pharma Holdings is known to have converted into a holding company in June 2017.

[Graph] Major stock price changes in the COVID-19 (Nafamostat) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Jeil Pharma Holdings' quant financial score is 24.03 points, which is higher in growth and stability scores than the average of other stocks related to COVID-19 (Nafamostat), ranking 6th within the theme. This indicates that compared to other stocks in the theme, Jeil Pharma Holdings has a relatively fast increase in sales and net profit, and also shows good responsiveness to changes in domestic and international economic environments.

[Table] Top financial scores within the theme

※ The quant financial score is the result of the Robo Algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.